People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

REL-P11 is a proprietary, low-dose, modified-release psilocybin formulation Single-Ascending Dosing (SAD) study to evaluate safety and pharmacokinetics in obese and normal weight subjects With ...

Weight gain, particularly abdominal obesity, significantly impacts individuals with metabolic syndrome. It exacerbates ...

Zomedica Corp. ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the launch of ...

We have a fundamental problem with how our bodies make energy from food – so says Stanford-trained physician, Dr Casey Means, ...

Cardiovascular Kidney Metabolic (CKM) syndrome, an alarming, intricate interplay of lifestyle and the influence of ...

Bharmal told Financial Express.com. The long-term consequences of this metabolic dysfunction are extensive. Metabolic ...